BioSpace News Archive

BrightInsight, Inc., provider of the leading regulated Internet of Things (IoT) platform for biopharma and medtech, announced today a global digital health partnership with global biopharmaceutical leader, AstraZeneca.

Self-diagnosis, consultations with certified doctors, and corona virus tracking and triaging are all easily, quickly, and securely accessed by anyone, anywhere, who has a smartphone.

Only remote cardiac monitoring company whose proprietary connected system has FDA-approved indication to measure, analyze and report QT interval

The Prostate Cancer Foundation and Teams from the NBA and NHL Joined Forces to Help Raise Awareness and Funds to Fight Prostate Cancer

Today Berkeley Lights, Inc., announced the Global Emerging Pathogen Antibody Discovery Consortium (GEPAD) with founding members Dr. James Crowe and Dr. Robert Carnahan at Vanderbilt University Medical Center, Dr. Erica Ollman Saphire at La Jolla Institute for Immunology and Dr. Frances Eun-Hyung Lee at Emory University with the aim to accelerate the discovery of neutralizing antibodies from patient blood samples

U.S.-based Brooklyn Bedding has announced it will repurpose its proprietary technology, developed 16 years ago to meet a desperate need in the trucking industry, to produce hospital beds in the face of the COVID-19 pandemic.

Braintree Company Creates Non-Medical Face Mask to Help Limit Civilian Exposure to COVID-19

Secarna Pharmaceuticals GmbH & Co. KG (“Secarna”), a biopharmaceutical company focusing on the discovery and development of next generation antisense oligonucleotide (ASO) therapies to address challenging or previously undruggable targets via its LNAplusTM platform, today announced that the Company signed a Research, Development and Transfer Agreement with Lipigon Pharmaceuticals AB (“Lipigon”).

Maryland Rye distiller advised by Johns Hopkins on WHO- and FDA-compliant manufacturing of vital sanitizer

AIDS Healthcare Foundation (AHF) today is calling on Gilead Sciences Inc., one of the largest manufacturers of HIV/AIDS drugs, to immediately abandon its claim for “orphan drug” designation for remdesivir, an antiviral drug thought to have some promise in the treatment of COVID-19.